Drug search by name

Mesalamine Long-Acting Capsules (Apriso) and Liver dysfunction

Result of checking the interaction of drug Mesalamine Long-Acting Capsules (Apriso) and disease Liver dysfunction for safety when used together.

Check result:

Mesalamine Long-Acting Capsules (Apriso) <> Liver dysfunction

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of mesalamine and other compounds which contain or are converted to mesalamine has been associated with hepatic adverse effects, including hepatic failure. Therapy with mesalamine and prodrugs of mesalamine should be administered cautiously in patients with impaired hepatic function or a history of liver disease. Liver function should be evaluated prior to initiation of therapy and periodically during therapy.

Mesalamine Long-Acting Capsules (Apriso)

Generic Name: mesalamine

Brand Name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa

Synonyms: Mesalamine

What is Mesalamine Long-Acting Capsules (Apriso)?